0426 GMT - China's infant formula market sales will likely keep falling this year due to the shrinking infant population, but at a slower pace than in 2023, Citi analysts say in a research note. China's infant population could decline 5% in 2024, compared with 9% in 2023, the analysts say. Citi expects intensified market competition and consolidation in 2024. China Feihe will likely keep facing topline pressure, gross profit margin contraction, and declining earnings in 2024. Health & Happiness (H&H) International Holdings' early move to a health supplement business will bear fruit and continue to drive growth in 2024, the analysts say. A2 Milk's 1H result might be better than expected as the company recently reiterated its 2024 earnings guidance, they add. (sherry.qin@wsj.com)
(END) Dow Jones Newswires
January 17, 2024 23:26 ET (04:26 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments